Performance reporting

Outcome 1 Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements

DELIVERABLE/KEY PERFORMANCE INDICATOR (KPI)	OBJECTIVES
SECURE THE SUPPLY OF BLOOD AND BLOOD PRODUCTS
New Australian Red Cross Blood Service contract arrangements are progressed	Reference Point/Target:	National Service Standards, the expectations for Australian Health Providers and the National Inventory Management Framework (NIMF) are implemented. Payment and Substitution Rules and the outcome from the review of the National Managed Fund (NMF) are progressed and negotiations of a revised contract commenced.
	Result:	Met. First phase of National Service Standards, expectations for Australian Health Providers as the Health Provider Charter, NIMF for red blood cells implemented. Outcome from the review of the NMF approved. Other targets progressed.
Provision of an adequate, affordable and secure supply of blood and blood products	Reference Point/Target:	Blood products are available to meet clinical need.
	Result:	Met. Blood and blood products were provided to meet all clinical demand without interruption.
Variance between actual and NBA estimated demand for supply of products	Reference Point/Target:	<5 per cent.
	Result:	Met. Variance across all major product group was less than 5 per cent.
IMPROVE RISK MANAGEMENT AND BLOOD SECTOR PERFORMANCE
Review of the clinical and administrative management of intravenous IVIg is implemented	Reference Point/Target:	Recommendations of the Review to improve governance of Ig products are implemented in accordance with Governments' decisions.
	Result:	Met. Implementation of recommendations progressed in accordance with Governments' decisions and timetable.
Percentage of national blood supply processed by laboratories interfaced to BloodNet	Reference Point/Target:	20 per cent.
	Result:	Met. 24 per cent of national blood supply is processed by laboratories interfaced to BloodNet.
PROMOTE THE SAFE AND EFFICIENT USE OF BLOOD AND BLOOD PRODUCTS
National data strategy and National Patient Blood Management (PBM) Guidelines Implementation strategy are progressed	Reference Point/Target:	Performance scorecard is published. The standards and minimum data sets for blood sector data are developed. The National Reference Set of PBM implementation tools is published.
	Result:	Met. The performance scorecard published. Standards and minimum data sets are developed for haemovigilance reporting, transfusion/use reporting by DRG and procedure and red cell data linkage. NBA PBM reference tools and resources published.
Number of clinical practice guidelines published	Reference Point/Target:	One.
Number of clinical practice guidelines published	Result:	Met. Module 5 of the Patient Management Guidelines (PBM) (Obstetrics and Maternity) was published in March 2015.
There is a robust framework supporting best practice management and use of blood and blood products	Reference Point/Target:	A sustained improvement in the management and use of blood.
	Result:	Met. The demand for blood continues to decrease significantly as a result of improved appropriate use. As an example, the demand for red cells decreased by approximately 5 per cent in 2014-15.

Objectives
Secure the supply of blood and blood products	Improve risk management and blood sector performance	Promote the safe and efficient use of blood and blood products
Key Programmes and Initiatives
National Supply Plan and Budget (p.21) Contract Management (p.33) Deed of Agreement with Red Cross (p.33) CSL Australian Fractionation Agreement (p.35)	Ig Governance (p.38) Evaluation of New Products (p.40) Data Developments (p.40) Risk Management (p.41) ICT Developments (p.42) Sector Monitoring (p.46)	Reference Development (p.47) Implementation (p.48) Best Practice Tools (p.49) Promotion and Communication (p.50) Education and Training (p.54) Research and Development (p.57)